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THE PREVALENCE OF DIETARY SUPPLEMENT USE AMONG OLDER ADULT
POPULATION USING NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY
(NHANES) 2009-2012
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Advisor: Patricia Slattum, Pharm.D., Ph.D.
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Department of Pharmacotherapy and Outcomes Science

Background: Dietary supplements (DS) use has increased in the U.S. in the past 20 years. More
than half of the U.S. population reported using DS. There are few studies to our knowledge that
have assessed DS use specifically for older adults. In this study we purposed to evaluate the
trend of using DS among older adults and to test the association between using DS and several
demographics, socioeconomics and health characteristics. The second objective was to evaluate
the reasons behind using DS among older adults using a nationally representative database.
Methods: This is a cross sectional study using the most recent National Health and Nutrition
Examination Survey (NHANES) database 2009-2012. It is a nationally representative sample of
noninstitutionalized adults in the U.S. Frequency and weighted percentage (standard error) were

reported for dichotomous variables. Multiple logistic regressions model analyses were used to
evaluate the predictors of DS use after testing model assumptions, multicollinearity, and outliers.
P values 0.05 were considered significant. All the statistical analyses were conducted using SAS
software version 9.4.
Results: Out of 2625 older adult participants (65 years and older) 70.5% of them reported using
DS in the past 30 days. Female, non-hispanic white, obese, overweight and excellent and very
good self-reported health status participants were more likely to use DS. Multivitaminmultiminerals (MVMM), calcium and vitamin D were the most commonly reported supplements
among older adults. 71% of oldest old (80≥ years) reported taking DS and prescription
medication in the past 30 days concomitantly and 73% of polypharmacy users reported using
DS. To stay healthy, to improve overall health and for bone health were the most commonly
reported reasons behind using DS.
Conclusion: majority of older adult participants reported using DS in the past 30 days. Health
care professionals need to evaluate the dietary supplement information from older adults in order
to improve health care.

CHAPTER 1 INTRODUCTION
This chapter explains the trend of DS use in the past 20 years among U.S. adults, DS
regulation in the U.S., brief background about older adults in the U.S., polypharmacy related
issues, and study significance. Chapter 2 reviews the recent studies (2004-2014) that have
focused on prevalence of DS among U.S. adults. Chapter 3 provides study design, and
inclusion/exclusion criteria for the study population and statistical analysis methods. Chapter 4
presents the results of each specific aim. Finally, Chapter 5 provides discussion, strengths,
limitations, future direction, and conclusion for this project.
The 1994 United States Dietary Supplement Health and Education Act (DSHEA) defines the
term dietary supplement (DS) as “a product taken by mouth that contains a dietary ingredient to
supplement the diet”(“Q&A on Dietary Supplements,” 2014). Dietary ingredients may include
vitamins, minerals, herbs or other botanicals, amino acids, enzymes, organ tissue, glandulars, and
metabolites. Before DSHEA 1994, DS were subject to the same regulatory requirements as other
foods, but now, under DSHEA 1994, the manufacturer has full responsibility for the safety and
labeling of DS. The prevalence of DS use in the United States has increased over the years since
DSHEA 1994 was enacted (Gahche et al., 2011).
DS use is common among the U.S. adult population. In the National Health and Nutrition
Examination Survey NHANES 1988-1994, approximately 44% of the U.S. population reported
taking DS in the past 30 days (Gahche et al., 2011). In the same study approximately 30% of the
U.S. population reported taking multivitamins/multiminerals in the past 30 days (Gahche et al.,
2011). After 18 years the percentage has increased to 53% reporting taking DS and 39%
reporting taking multivitamins/multiminerals in NHANES 2003-2006 (Bailey et al., 2011).
According to the U.S Government Accountability Office GAO report 2009, the total sales of DS
1

has increased from 14$ billion in 1997 to 22$ billion in 2007 as shown in figure 1-1 (States &
Accountability, 2009).

Figure 1-1 Total sales of Dietary supplement in the United States from 1997 through 2007 according
to GAO report.
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United States Regulation of Dietary Supplements:
There are several pieces of legislation that have been enacted to regulate DS use and safety in
the USA. The major legislation addressing DS use before DSHEA-1994 were the Food, Drug,
and Cosmetic Act of 1938 (FDCA), the Proxmire Amendment, and the Dietary Supplement Act
of 1992 (DSA). As DSHEA 1994 is the most recent DS regulation in the USA, a brief review of
this regulation is discussed below.
According to DSHEA-1994, DS have a separate new category of regulation for safety and
labelling issues, unlike before DSHEA-1994 when DS were subject to the same regulatory
requirements as other foods. Under DSHEA-1994, a manufacture has the full responsibility to
make ensure that the DS is safe and properly labeled. The manufacturer is only required to
notify FDA if it intends to market a DS that contains a new “dietary ingredient”. In addition,
FDA requires certain information has to be in the label such as the name of the product, a
statement that it is a supplement, the name of the manufacturer, a complete list of ingredients, a
declaration that the supplement does not require FDA review or approval, and the disclaimer
statement “This statement has not been evaluated by the FDA. This product is not intended to
diagnose, treat, cure, or prevent any disease”. By DSHEA low, the manufacturer and distributer
are responsible for investigating and reporting to FDA any report they receive of a serious
adverse event within 15 days. FDA has the responsibility to show that the DS is unsafe after the
product is released to the market. That means there are no studies required to be done on the
product efficacy or safety before introduction to the market.
More than half of U.S. adults reported using DS in the past 30 days (Eileen T. Kennedy, Hanqi
Luo, 2013) and this study shows that reporting using DS increases with age. 42% of U.S. older
adults (57-85 years old) reported using Over The Counter (OTC) medication in the past 6 months
(Qato et al., 2014). In addition, 48% of older adults form the same study reported using DS in the
3

past 6 months (Qato et al., 2014). DS prevalence is increasing among older adults due to the
misperception that DS are safer than OTC or prescription medications, while still the safety and
efficacy of DS is not well established (Nahin et al., 2009). Cultural, philosophical, and religious
beliefs play an important role in increasing DS use among U.S adults (Nahin et al., 2009).
Older Adults in the USA:
Older adult is a term referring to a person who is 65 years or older. Today, there are almost 40
millions persons aged 65 years and older living in the United States and this number is expected
to increase to 89 millions persons in the next 40 years (Jacobsen, Kent, Lee, & Mather, 2011).
This rapid change in population characteristics can lead to economic, social, and health care
consequences, especially if the healthcare system does not prepare for this change (Jacobsen et
al., 2011). Many older adults have several comorbidities and receive more than one prescription
medication, which may lead to difficulty managing their health and maintaining their quality of
life. Also, older adults experience physiologic changes associated with aging affecting their liver
and kidney function, which make taking DS that have been never tested on this specific
population potentially more risky and more likely to result in an adverse outcome.
Polypharmacy:
Polypharmacy is also a concern for older adults. The pattern of polypharmacy is expected to
increase in the next few years among the older adult population. Kaufman et al. found that more
than half of US older women use more than 5 prescription medications and 12% of them take
more than 10 medications per day (Hajjar, Cafiero, & Hanlon, 2007). There are several
definitions of polypharmacy proposed in the literature. Use of six or more medications or using
at least one potentially inappropriate medication listed on the Beers list (2012) indicating that the
risk generally outweighs the benefit for most older adults are the most common definitions of
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polypharmacy. (Riker & Setter, 2012). Polypharmacy is a very important issue among older
adults because it increases the risk of adverse drug reactions (ADRs) and drug-drug interactions
(Mallet, Spinewine, & Huang, 2007). Using DS by patients taking prescribed medications will
increase the risk of DS-drug interactions and ADRs, which may lead to increased rates of
hospitalization, mortality and morbidity of older adults.
Specific Aims and Significance:
The main objectives of this project are to document the prevalence of DS use among the U.S.
adult population and older adults specifically, and to identify demographic and socioeconomic
predictors of DS use by analyzing data available from the National Health and Nutrition
Examination Survey NHANES 2009-2012.
The specific aims for this study are:
1) To determine the prevalence of DS use among older adults 65 years and older using
NHANES 2009-2012 data.
Previous studies have shown that the prevalence of DS use is increased among older adults,
although those over the age of 71 years have not been included in previous analyses. Older adults
are at high risk of polypharmacy and comorbidities, increasing their risk of supplement-drug
interactions or disease-supplement interactions.
2) To assess the relationship between DS use and demographic and socioeconomic
characteristics.
Identifying characteristics with a significant association with DS use may be helpful to
improve patient health and patient care by facilitating targeting of health care interventions to
patients at greatest risk for using DS.

5

3) To evaluate the reported reasons for using dietary supplements among older adults.
Knowing the reasons for DS use in this population may help health care professionals better
understand why older adults may use DS and identify opportunities to improve the use of DS in
this population.
Several studies have reported the prevalence of DS among all ages in the U.S. adult
population. However, lack of consistency of defining older adults age interval in those studies
make it difficult to provide a conclusion specifically for older adults. Most of our objectives in
this study were focused on older adults (65 years and older). This is the common age interval for
older adults that has used in the previous studies in the health care field. This study will be the
first study to evaluate the use of DS specifically among older adults in the U.S. using the most
recent cohort available from NHANES. The results of the study will contribute to understand the
most common reported reasons for using DS that have used in the past 30 days. Knowing the
prevalence and the reasons of DS use may overcome some of the challenges related to DS-drug
interaction, DS-disease interactions, or unknown side effects that may appear on older adults due
to DS use. The results of the study will document the extent of use of DS among older adults and
serve as the basis for further research on the impact of DS use on the health of older Americans.

6

CHAPTER 2 LITERATURE REVIEW
This chapter describes recent research findings regarding DS use in the U.S. There are several
studies that have discussed the trends in DS use among the U.S. population with different clinical
situations for example, use of DS among cancer patients, use of DS among cardiac disease
patients, and use of DS in combination with medications to treat certain medical conditions. In
this literature review only the prevalence or trend of using DS among the general U.S. adult
population will be discussed, without focusing on a specific disease or population.
Literature Review Objectives:
The objectives of this literature review are to:
-

Document the recent prevalence of DS use among the adult U.S. population;

-

Identify confounders and predictor variables that affect DS consumption;

-

Evaluate previous studies and identify “gaps” in the literature in order to inform the design
of a new study focusing on DS use among older adults in the U.S.;

Search Strategy:
Studies were identified using comprehensive English MeSH terms in PubMed and CINHAL.
MeSH terms and subheadings used included “Dietary Supplements/Utilization” AND Aged, OR
80 year and older, OR Frail Elderly. The titles, abstracts, and relevant citations were reviewed,
and inclusion and exclusion criteria were applied to determine which studies to include in the
review.
Inclusion Criteria:
-

Included older adults (65 years and older)

-

Used recent data or recent publications (from 2004 to 2014)
7

-

Used nationally representative databases like NHANES or NSHAP

-

Conducted in the U.S. with the U.S. population.

Exclusion Criteria:
-

Used specific populations that may limit the generalizability of the results such as focusing
on DS use among cancer patients or cardiac patients

-

Was conducted outside the U.S. or using non U.S. population

-

Excluded the older adult population

The Newcastle-Ottawa Quality Assessment scale was used to critically evaluate the studies. This
tool is appropriate to critique cohort, cross-sectional and case control studies.
Results:
Out of 375 unique articles identified and screened from both databases (PubMed and
CINHAL), there were six studies that met the inclusion and exclusion criteria. All of them were
cross-sectional studies. Three studies used NHANES (“National Health and Nutrition
Examination Survey : Plan and Operations , 1999 – 2010,” 2010), one study used the National
Health Interview Survey (NHIS) (Services, 1997), one study used the National Social Life,
Health and Aging Project (NSHAP) (“National Social Life, Health, and Aging Project
(NSHAP), NORC.org,” 2014), and the last study used data collected for the Ginkgo Evaluation
Memory (GEM) study (“Questions and Answers: Ginkgo biloba for the Evaluation of Memory
(GEM) Study, NCCIH,” 2014). Table 2-1 summarizes each study that met the
inclusion/exclusion criteria.
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Review of Methodology Used in the Selected Studies:
Five of the six studies identified were derived from nationally representative survey-based
datasets such as NHANES and NHIS. One study used data from a randomized double blind,
placebo controlled trial (RTC), a multicenter trial to increase the study internal validity,
reliability. Four reviewed studies were conducted based on noninstitutionalized, household
population surveys, while two studies were based on community dwelling adults. All of the
previous studies were inconsistent with defining the older adult age interval even among those
studies that used the same database. For instance, there were three studies from NHANES and
the definition of older adult was either from 60-69 years, or greater than 71 years, or greater than
60 years old. In the GEM study, older adult was defined participants greater than 75 years old,
while in the NSHAP study, the analysis was based on the older adult population from 56 years
old to 85 years old. In the NHIS study, the older adult age interval was defined as greater than
65 years old, which is the same age interval that we used in this study consistent with most of
the studies in geriatrics field as well. Thus, variability of defining the older adult age interval
makes comparing the results difficult.
DS information is another place that we could see variability between the previous studies.
All NHANES based studies have used the short term used of DS, which was reported as the DS
use in past 30 days, while the NSHAP study has used daily or weekly use. GEM study reported
the DS use within the previous two weeks from the interview day and finally the NHIS study
considered the DS use for the previous 12 months period. Most of the reviewed studies defined
DS based on DSHEA definition. DS information was collected via home interview and self
reported questionnaires among all reviewed studies, which may lead to recall bias or selection
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bias and may result in overreporting or underreporting of important information related to DS
use.
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Table 2-1 Summary of all the previous studies that met the inclusion and exclusion criteria.

Study

Setting and sample size

Data source

Conclusion

Kennedy, et al., 2013

Noninstitutionalized
participants, 20-69 years old.
Only the population estimate
was reported.
Noninstitutionalized, 37516
participants for all ages older
than 1 year
Noninstitutionalized, 11956
adult participants >20 years old

NHANES

Half of the U.S. population used DS. The
percentage of DS users increased while the
participants getting older.

NHANES

Gardiner, et al., 2006

Noninstitutionalized, household
population. 31044 participants
(includes 18 years and older.

NHIS

Qato, et al., 2008

Community dwelling persons
2976 participants (aged 57 to 85
years)
Community dwelling older
adults (>=75 years) 3070
participants

NSHAP

70% of older adults aged >71 years used DS in
the past 30 days. The most common supplement
was a multivitamin/multimineral supplement.
49% of U.S. adult reported using DS in the past
30 days. 45% of reported reasons for taking DS
was to improve or 33% to maintain health. Older
adults were more likely to use DS than younger
adults.
21% of those who used prescription medications
also used Nonvitamins dietary supplements
NVDS in the past 12 months. Being female and
younger were the factors most strongly
associated with using NVDS.
Among prescription users and OTC users, 68%
of them also used a DS in the past year.

Bailey, et al., 2010

Bailey, et al., 2013

Nahin, et al., 2009

11

NHANES

GEM

74% of older adults who used prescription
medications also used at least one DS.

Some studies assessed the prevalence of DS use across all ages, but most of them focused on
adults over 18 years of age. Two studies were conducted using databases that only included older
adults in their database such as NHIS and NSHAP. Few studies have examined concurrent use of
medication and DS along with the prevalence of DS use. Only one study evaluated drugsupplement interactions among older adults. This study used Micromedex to define the drugsupplement interactions included in the analysis.
Review of the Prevalence of DS use and the motivation of using DS in the Studies:
Bailey et al. in the most recent study conducted using NHANES (2007-2010) found that 49%
of U.S. adults over 20 years old reported using DS in the past 30 days (Bailey, Gahche, Miller,
Thomas, & Dwyer, 2013). 67% of older adults (>60 years old) were DS users in Bailey study
(Bailey et al., 2013). Female, older adults (>60 years old), non-hispanic white, normal BMI,
highly income participants, former smokers, self reported excellent or very good health status
were more likely to report using DS than other population (Bailey et al., 2013). Multivitaminmultiminerals (MVMM), calcium, omega-3/fish oil, and botanicals were the top 4 DS reported
in the same study by 32%, 11.6%, 10%, and 7.5% respectively. Kennedy et al. found in the
second most recent study using (NHANES 2007-2008) that almost 50% of the U.S. population
used at least one DS in the past 30 days (Eileen T. Kennedy, Hanqi Luo, 2013). In the same
study the percentage of DS use was increasing while the age of the U.S. population is increasing
as well. In the same study the authors found that DS use was more likely in females, older
adults, highly educated people (having college graduate degree or above), and non-hispanic
whites (Eileen T. Kennedy, Hanqi Luo, 2013). Bailey, et al. found similar results using an
earlier NHANES cohort (2006); 49% of the U.S population used at least one DS in the past 30
days (Bailey et al., 2011). Eighty percent of those users reported taking the DS every day during
12

the past 30 days. Females, older adults (greater than 71 years old), highly educated people
(having greater than high school degree), and overweight participants were more likely to use
DS in this study (Bailey et al., 2011). Multivitamins and multiminerals (MVMM) was the
highest reported DS use at 33%, followed by botanical supplements used by 14%.

Because

there was limited information available regarding DS use and concurrent use of prescription
medication among older adults, Qato, et al. conducted a study to determine the prevalence of
prescription medication and DS use among older adult in the U.S. and evaluate drug-supplement
interactions. This study used the NSHAP database of older adults aged 57 to 85 years. Fortynine percent of this population was reported using DS (Qato et al., 2008). In this study, 68% of
the population was using DS and prescription medication concurrently, which may lead to
adverse events due to drug-supplement interactions or disease-supplement interactions
especially among older adults who often have more than one medical condition and take
multiple prescription medications (Qato et al., 2008). Consistent with this study, Nahin et al.
evaluated the concomitant use of prescription drugs and DS in ambulatory older people (≥75
years old) using data collected as part of the GEM study. Nahin et al, found that almost 82.5%
of study participants used at least one DS and 55% using three or more DS with an average of
three DS per participant (Nahin et al., 2009). Ninety percent of DS users were reported using at
least one prescription medication, and among all study participants 75% of them reported using
at least one DS and one prescription medication (Richard.L. et al., 2009). Multivitamins, iron,
and vitamin E were the most commonly used DS among older adults at 60%, 59%, and 44%
respectively (Richard.L. et al., 2009).
From NHIS, Paula, et al. found that 21% of those who used prescription medications also
used non-vitamin DS (NVDS) in the past 12 months (P Gardiner, Graham, Legedza, Eisenberg,
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& Phillips, 2006). Unlike previous studies, Paula et al. found that younger participants (≤24
years old) were more likely to use NVDS compared to older adults (≥65 years old) or middle
aged (45-54 years old) participants. Also Paula found that NVDS use was more common among
those with non-life threatening conditions such as menopause, insomnia, and chronic pain (P
Gardiner et al., 2006). Among all the previous studies there was only one study that examined
the reasons of using DS among >20 years old U.S. population using (NHANES 2007-2010). To
improve overall health, to stay healthy, for bone health, to supplement the diet, and to prevent
health problems were the top 5 reasons for using DS among U.S. adults by 45%, 33%, 25%,
22%, 20.5% respectively (Bailey et al., 2013).
Factors Associated with DS use:
Table 2-2 shows the list of the factors that have been evaluated with DS users in the previous
studies. Only seven factors were significantly associated with DS users among all ages including
age, race, education, gender, BMI, family income, and region. The rest of the 22 variables they
studied were not significantly associated with DS users.
Most studies agreed that older adults consume more DS and alternative medicine than
younger age groups (Bailey et al., 2013) (Eileen T. Kennedy, Hanqi Luo, 2013) (Bailey et al.,
2011) (Qato et al., 2008). In addition, females, highly educated participants, non-hispanic
whites, and insured participants were more likely to use DS. Gardiner et al. examined the factors
associated with DS use only among those who take prescription medications (P Gardiner et al.,
2006). Paula et al found that females, cigarette smokers, hispanic or non-hispanic whites, and
those living in the West (compared to the Northeast) were more likely to use nonvitamin dietary
supplements (NVDS). Surprisingly, in the same study they found that younger participants were
more likely to use NVDS compare to older adults or middle aged individuals (P Gardiner et al.,
14

2006). Also, the study showed that prescription users for menopause, insomnia, chronic pain,
and sever headache tend to use NVDS greater than those who used prescription medications for
hypertension, hyperlipidemia, or diabetes. (P Gardiner et al., 2006).
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Table 2-2 Factors that have been evaluated with DS use in the previous studies.

Factor

Kennedy,

Bailey,2010

Bailey,2013

Gardiner,

Qato,

Nahin,

2013
Age*













Race*













Gender*













Education*











BMI*









Income*





Smoking





Health Insurance





Exercise







Health status









Chronic condition
Household food security












status
Household food benefit




Alcohol use



Region*



Usual source of medical



Last visit to health



professional
Church attendance



Club attendance



Reading senior magazine



Reading Bible



Difficulties of DLA or



IDLA
*variables were significantly associated with DS in the previous studies at 0.005 level of significant.
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Review of concurrent use of prescription medications with DS:
Three of the studies examined concomitant use of DS with prescription drugs. A study by
Qato et al, showed that 68% of older adults used DS in combination with prescription
medications (Qato et al., 2008). In the GEM randomized control trial, Nahin et al., found that
83% of older adult medication users also used DS (Richard.L. et al., 2009). Moreover, the same
study showed that 90% of DS users have also used prescription medications (Nahin et al., 2009).
Aspirin, statin medications, and beta blockers were the most frequent medications that were
combined with DS (Richard.L. et al., 2009). The study by Gardiner et al. showed that only 21%
of prescription medication users also used NVDS in the past 12 months, but this study only
focused on NVDS without examining all DS as considered in the other two studies(P Gardiner
et al., 2006). There are few studies examining the concomitant use of prescription medications
and DS among older adults, and more work in this area is needed.

Possible adverse

consequences associated with concomitant use of prescription medications and DS are also
poorly understood.
Conclusion:
This review was conducted to assess the current literature evaluating the prevalence of DS
among the U.S. older adult population using nationally representatives databases. Twelve
studies were identified but only six studies were conducted within the most recent 10 years
period (2004-2014). This specific time period was focused on because the current prevalence is
most likely to be related to the more recent studies that have been conducted. These previous
research studies conducted in the past decade used nationally representative datasets that are
well-documented methodologically such as NHANES, and NHIS. Only one study focused
exclusively on NVDS (Paula Gardiner et al., 2014). Three articles examined the use of DS
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among prescription medication users. One study was focused on the most commonly reported
motivations for using DS among U.S. adults population.
The most recent study that evaluated the patterns of use of DS among the U.S. population
used the 2010 NHANES cohort. Most of the studies found that using DS was more likely among
older adults, females, highly educated participants, insured individuals, and overweight people.
Age, sex, marital status, level of education, annual family income, race/ethnicity, health
insurance, smoking status, body mass index, and region of U.S. resident were the most common
variables tested in the previous studies. In addition, more predictors were evaluated in our study
like polypharmacy, concomitant use of prescription medications and DS, and hypertensive
participants. Those three factors were associated in previous studies with an increased rate of
drug-drug interactions and adverse drug reactions (Brazier & Levine, 2003). While most of the
previous studies agreed that older adults were more likely to use DS, there is need for a study
using more recent data conducted specifically in this population. All the reasons and factors
associated with reported DS in the previous studies were tested among all ages not only for
older adults. For that reasons conducting a specific study in the older adults population is
necessary. Older adults are generally at greater risk for drug-drug interactions, drug-supplement
interactions, disease-supplement interactions, and polypharmacy due to multiple health
conditions (Brazier & Levine, 2003). It is very important to focus on this population to
ultimately minimize the risk of ADRs and unnecessary medication use, as well as improve
quality of life.
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CHAPTER 3 METHODS
This chapter details the study design, population of interest, included variables, and statistical
analyses methods used to conduct this study.
Aim of the Study:
There are three main objectives in this project:
1- To determine the prevalence of dietary supplements use among older adults 65 years and
older in the U.S. using NHANES 2009-2012 data.
2- To assess the relationship between dietary supplement use and demographic and
socioeconomic characteristics among the U.S. older adult population (aged 65 years and
older).
3- To evaluate the most commonly reported reasons for using dietary supplements among
older adults in the U.S.
Study Design:
A retrospective cross sectional study design was used to conduct this study using NHANES
(2009-2010 and 2011-2012) cohorts. These are the most current data available publicly for
NHANES and will provide the most up-to-date picture of DS use among the U.S. population in
general and older adults specifically using NHANES.
Data Source:
NHANES is a survey that is designed to assess health and nutritional status of adults and
children in the United States (“National Health and Nutrition Examination Survey : Plan and
Operations , 1999 – 2010,” 2010). This data is the only free publicly available data source that
contains a separate dietary information file, including DS use and some details about the DS use.
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This survey examines a nationally representative sample of approximately 5000 persons each
year using a complex, stratified, and non-institutional cluster sample design that allows for
generalization to the entire U.S. population (“National Health and Nutrition Examination
Survey : Plan and Operations , 1999 – 2010,” 2010). NHANES participants were selected
randomly using a computerized system following these four stages. First was county selection,
second was selection of a block within that county, third was selection of a specific household
within that block, last stage was selection of individuals within a household. Computer-assisted
personal interview system and Blaise software was used to assess the qualified participants
within each household. More detail about sample selection can be find in the NHANES Plan and
Operations manual (“National Health and Nutrition Examination Survey : Plan and Operations ,
1999 – 2010,” 2010). One unique aspect of this data is that it contains both the dietary
information collected from household interview and examination information collected via the
Mobile Examination Center (MEC). It has five main files, including a demographic file,
examination file, laboratory file, questionnaire file, and dietary file. Only four files were used to
conduct this study (demographic file, examination file, questionnaire file, and dietary file). The
overall unweighted interviewed response rate for NHANES 2009-2010 was 79.4%, while the
response rate for NHANES 2011-2012 was 72.6% for all ages.
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Study Population:
The study population consisted of non-institutionalized adults who completed the dietary
information survey from age 20 years through 80 years old and older. Individuals aged 80 and
older are not identified by their specific age to protect their privacy.
Inclusion Criteria:
-

All individuals age of 20 years and older

Exclusion Criteria:
-

Children 19 years old or younger

Dietary Supplements Information:
The questionnaire survey includes many topics related to health like, DS used, medications
used, and medical conditions. The most important file needed to conduct this study was the DS
file. NHANES has two DS files, the first one related to the individual DS information, which has
the supplement details and the motivations for each supplement. The second file was related to
the total DS information, which has the question related to DS use and the frequency of the
supplement that has used in the past 30 days. Both files are needed to conduct this study. The
DS use information was collected during the household interview process. The interviewer asked
the participants “Have you used or taken any vitamins, minerals, or other dietary supplements in
the past month?”. If the participants answered yes, the interviewer asked to see the DS container
(Figure 3-1). If the bottle was not available, participants were asked to recall the name of the
DS. Additional questions related to DS use were asked such as “Was the DS recommended by a
physician, colleague or friends, or chosen on your own?”. Answers to these questions were
evaluated as part of this analysis. All of this information was obtained from individual and total
DS files (DSQIND, DSQTOT).
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Figure 3-1 The process of how the DS information was collected in NHANES survey 2009-2012.
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Reasons for Using Dietary Supplements:
This DS information was collected during the household interview process. In the
questionnaire, more than 30 options for reasons for using DS in the past 30 days were provided.
In this study, the top reported reason for each individual DS was evaluated. Also, the most
common reasons that were reported in general were studied. Any reason that had less than 100
observations was recoded as “other”. The Reasons for using DS are listed in Table 3-1.
Polypharmacy and Dietary Supplements:
Polypharmacy was defined as using 4 or more prescription medications (Bikowski, Ripsin, &
Lorraine, 2001) (Fulton & Allen, 2005). This information on medication use was obtained from
the Questionnaire file. Medication file only has prescription medications, which needed a
physician to be prescribed. Over the counter medications and DS are listed in separate files. The
interviewer asked the participants if they had taken any prescription medication in the past 30
days. The response to this question is dichotomous (yes/no). Another important variable was the
number of prescription medications that each participant was using regularly in the past 30 days.
Any participants that were using 4 or more prescription medications we categorized as a
“polypharmacy” patient. All of this information was obtained from the medication file
(RXQ_RX).
Covariates:
All demographic factors were tested in the descriptive and analytical analysis. Demographic
characteristics included age, race/ethnicity, gender, marital status, annual family income, and
education level. These were the most common variables evaluated in previous studies examining
similar objectives as this study. All of these variables were categorized as in previous studies or
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according to the number of observations in each group to facilitate comparisons with previous
studies. If any category in any variable had a small number of observations, we categorized that
group as “other”. Age was truncate by NHANES at 80 years and we categorized the age variable
into six groups, from 20-39 years, 40-64 years, and older adults as 65 years and older (65-69, 7074, 75-79, and 80≥). Race/ethnicity was categorized as non-hispanic white, non-hispanic black,
Mexican American/other hispanic, and other. Education level was categorized as high school or
less, undergraduate degree, and graduate degrees. Other variables included self reported health
status (excellent/very good, good, fair/poor), using antihypertensive medication (yes/no), and
polypharmacy (yes/no) if the participant was taking 4 or more medications in the past 30 days.
Systolic and diastolic blood pressure elevation were assessed by taking the mean of four systolic
readings and the mean of diastolic readings. It is considered systolic elevation if the mean four
readings was greater than 140, and considered diastolic elevation if the mean four readings was
greater than 90. Any responses provided as “Refused”, “Don’t Know”, or “Missing” information
were recoded as missing information. All the vitamins and minerals were recoded according to
Table 3-1. Concatenating each two files was done first then merging all the files under one
dataset by the common identifier (SEQN). For example, concatenating two DEMO files (DEMO
2009 and DEMO 2012) then merging the DEMO file with the rest of the files that we cleaned up.
We exclude any variable that had large numbers of missing observations like the cholesterol
diagnosis variable had more than 3000 missing observation. After completing all the data
cleaning and recoding each variable, SAS codes were reviewed by a SAS expert as a second
check.
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Table 3-1 Variables used in the analyses according to NHANES manual book.

File name
1- DEMO1

2- DSQIDS2

Variable name
RIDAGEYR
RIAGENDR
RIDRETH1
DMDMARTL
INDFMIN2
RIDEXPRG
DMDEDUC2
DSDSUPP
DSQ124
DSQ128A
DSQ128C
DSQ128D
DSQ128E
DSQ128F
DSQ128G
DSQ128H
DSQ128I
DSQ128J
DSQ128K
DSQ128L
DSQ128M
DSQ128N
DSQ128O
DSQ128P
DSQ128R
DSQ128T
DSQ128U
DSQ128V
DSQ128W
DSQ128X
DSQ128Z
DSQ128AA
DSQ128BB
DSQ128DD
DSQ128EE
DSQ128FF
DSQ128GG
DSQ128II
DSQ128S
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Variable description*
Age at screening
Gender
Race/ethnicity
Marital status
Annual family income
Pregnancy status at exam
Education level
Supplement name
Took product on own or
doctor advice
For good bowel
For mental health
To prevent health problems
To improve overall health
For teeth
To supplement the diet
To maintain health/To stay
healthy
To prevent cold
For heart health
For eye health
For healthy joints
For skin health
For weight loss
For bone health
To get more energy
For anemia (low iron)
To maintain blood sugar
For healthy hair
For kidney and bladder health
For respiratory health
For allergies
Improve digestion
For menopause
For muscle related issues
For stress and relaxation
For CNS health
For liver health
Antioxidants
For gout health
Other

3-DSQTOT3
4-BMX 4
5-BPQ5

6-HSQ6
7-RXQ_RX7

DSDCOUNT
Total number or DS taken
DSD010
Any DS taken
BMXBMI
Body mass index
BPXSY1,BPXSY2, BPXSY3, 1st Systolic blood pressure
BPXSY4.
reading and 2nd, 3rd, and 4th
BPXDI1, BPXDI2, BPXDI3, 1st Diastolic blood pressure
BPXDI4.
reading and 2nd, 3rd, and 4th
BPQ040A
Taking prescribed medication
for hypertension
BPQ090D
Doctor told you to take
prescribed medication for
cholesterol
HSD010
General health condition
RXDUSE
Taken prescription medication
in the past 30 days?
RXDCOUNT
Number of prescription
medications taken?

* According to NHANES manual. 1 Demographic file, 2 Dietary supplement individual file, 3 Dietary supplement total file in the
past 30 days, 4 Measurements file, 5 Blood pressure and cholesterol file, 6 Health status file, 7 Prescription medication file.
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Statistical Analyses:
All statistical analyses were performed using SAS version 9.4. The combined NHANES
databases (2009-2012) were used to determine the weighted trend of DS use among all adult
ages and older adults specifically. Weighted frequency and row percentage of demographic and
socioeconomics characteristics were reported. In order to assess the association between
demographic and socioeconomic variables with DS use, multiple logistic regressions was
performed. Bivariate analysis and checking that the assumptions for multiple logistic regression
were performed before running the model. Two important assumptions were tested for each
variable. The first one was testing if the predictors linearly related to the log of odds of the
outcomes by performing the Lemeshow Goodness of fit test. The second test was checking if
there are any influential observations in each variable. Multicollinearity and outlier observations
were tested. Table 3-2 details how each supplement was categorized. Because a complex,
multistage sampling design was used to determine a representative conclusion about DS use
among U.S. population, PROC SUREVYFREQ with STRATA, CLUSTER, and WIEGHT for the
measurement file were used. DOMAIN statement was used in order to account for the entire
sample for variance estimation. The variables included in the model were based on previous
studies or theoretical relationships between the outcome and the predictors. Chi-square was
calculated to assess the relationship between the outcome variables and the rest of the covariates
using p-value 0.05 as the level of significance.
Ethical Consideration:
Due to using a publicly available de-identified data source this study met the definition of
exempt study, which was not necessary to be reviewed by Virginia Commonwealth University,
Institutional Review Board.
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Table 3-2 Classification created for most of the dietary supplement in NHANES (2009-2012).

Category
Multi-vitamin, Multi-mineral (MVMM)

Multi-vitamins (MV)
Calcium products
Fatty acid
Fiber and colon health
Botanicals

Joints supplements
Single supplements

Definition
Any product contains both multi-vitamin, and multi-mineral, OR
any product has three or more vitamins and one mineral
supplement
Any product contains two or more vitamins without containing any
mineral supplement
All products that have calcium as a primary supplement.

Examples
B-complex,
Centrum, and Tri,
Vi, Flor
Multi-vitamin, 2
Vitamin C and D
Calcium, Calcium
and magnesium
All products that contain OMEGA-3 or fatty acids
OMEGA-3
Any laxative product or product that contain fiber supplement
Metamucil Fiber
Capsules
Any herbal product or products have botanical ingredient without Garlic, Ginger,
vitamins or minerals
Gingko Biloba,
Ginseng
Any product contains joint supplement like glucosamine, MSM, Glucosamine,
or both
MSM
Any single supplement without any combination with other Vitamin C, B, D,
vitamins or minerals or botanicals
and Iron
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CHAPTER 4: RESULTS
This chapter describes the results from the analysis conducted for each aim described
previously. All the results were obtained using the most recent NHANES cohorts (2009-2012)
available. The purpose of combining two cohorts (2009-10 and 2011-122) was to increase the
number of participants, especially the older adult group. NHANES is a complex design cohort
for the non-institutionalized U.S. population, which allows our results to be generalized to the
U.S. adult population. The data was obtained from the CDC website and is freely available for
public use. In this study, the dietary file, demographic file, questionnaire file, and examination
file were used for the analysis. The main variables in this study were obtained from the
demographic and dietary files. After cleaning and recoding “Unknown” “Refused to answer” or
any inappropriate responding in each variable or observation and deleting the missing
information, we ended up with n=11,372 participants. Figure 4-1 and Figure 4-2 details about
the sample size distribution among both younger and older adults. Any variable having more
than 5% missing values was deleted according to listwise deletion method.
Overall, out of 11,372 participants approximately half of them used at least one DS in the past 30
days (50.83%) (Table 4-1). In our analyses we focused only on those who were using DS in the
past month to evaluate the trend of DS use among the U.S. population.
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Table 4-1 Prevalence of DS in the United State among all ages ≥20 years old using NHANES, 20092012.

DS use

Frequency

Weighted %

YES

5934

50.83%

NO

5438

49.16%
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Prevalence of dietary supplements use among U.S. population ages 20-64 years using
NHANES 2009-2012
Table 4-2 shows the descriptive characteristics of those who were using DS among the
younger adult population. Of the 11372 participants included in the study, only 8747 fell in the
younger population category (20-64 years) and this number were examined for this aim. Sample
frequency and weighted percentage were used to present these results. 46.61% of the younger
adult population reported taking at least one DS in the past 30 days. 56% of the younger adult
population was between 40-64 years of age and was more likely to use DS compared to 40% of
those between 20-39 years of age (Figure:4-1). Among this age group females were more likely
to report using DS than males (52% vs. 41%). Reported DS use by race is as follows: nonhispanic whites (51%), non-hispanic blacks (38%), Mexican American and other hispanic (32%),
and other (49%). Among the younger adult population, normal weight participants were more
likely to report using DS than underweight, overweight, and obese, (51%, 39%, 48%, and 42%
respectively). Moreover, as the family income increased, the percentage reporting DS use
increased from low to middle, and high family income (36%, 46%, 58% respectively). Also, as
the participants increased in the level of education, the percentage reporting DS use increased as
well (35% high school or less, 48% college degree, 60% graduate degree). The self reported
health status distribution was 54% reporting having excellent or very good health, 42% good
health and 41% fair or poor health. Half of the married participants reported using DS similarly
with divorced participants and 39% of the participants that they never married reported using DS
in the past 30 days.
In addition, 49% of the younger adult respondents (20-64 years) having either elevated
systolic or diastolic blood pressure also reported using DS. Fifty three percent of those who were
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taking antihypertensive medications reported taking DS. The differences between the groups in
each variable were statistically significant at 0.05 level of significant except the systolic/diastolic
elevation variable and treatment for hypertension, which were not significant.
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Figure4-1 Flow chart showing the distribution of the younger population (20-64 years old) who reported using DS in NHANES 2009-12
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Table 4-2 Prevalence and characteristics of those who reported using DS in the past 30 days among
the younger adult population (20-64 years), NHANES 2009-2012.

Characteristic
Freqa

DS use in the past 30 days
Yes
No
b
a
W.%(SE)
Freq
W.%(SE)b

Age*
20-39
1789
40 (1.3)
3120
60 (1.3)
40-64
1936
56 (1.3)
1902
44 (1.3)
Sex*
Male
1571
41 (1.2)
2669
59 (1.2)
Female
2154
52 (1.1)
2353
48 (1.1)
Race*
Non-Hispanic white
1621
51 (1.1)
1781
48 (1.1)
Non-Hispanic black
773
38 (1.1)
1215
62 (1.1)
Mexican American/other Hispanic
821
32 (1.2)
1497
67 (1.2)
Other
510
49 (2.2)
529
50 (2.2)
BMI*
Underweight
54
39 (4.6)
90
61 (4.6)
Normal
1112
51 (1.7)
1371
49 (1.7)
Overweight
1216
48 (1.6)
1600
52 (1.6)
Obese
1306
42 (1.1)
1918
58 (1.1)
Family income*
Low
1378
36 (1.2)
2483
64 (1.2)
Middle
1064
46 (1.5)
1398
53 (1.5)
High
1123
58 (1.6)
909
42 (1.6)
Education*
High school or less
1299
35 (1.3)
2692
65 (1.3)
College degree
1224
48 (1.4)
1441
52 (1.4)
Graduate degree
1197
60 (1.5)
884
40 (1.5)
Systolic/Diastolic elevation
Yes
454
49 (2.5)
616
51 (2.5)
No
3108
47 (1.1)
4141
53 (1.1)
Antihypertensive medications
Yes
932
53 (1.6)
940
47 (1.6)
No
181
45 (3.0)
261
55 (3.0)
Health status*
Excellent/ very good
1398
54 (1.1)
1461
46 (1.1)
Good
1267
42 (1.6)
1808
57 (1.6)
Fair OR poor
642
41 (1.9)
1078
59 (1.9)
Marital status*
Married
2245
49 (1.3)
2880
51 (1.3)
Never married
774
39 (1.6)
1325
61 (1.6)
Divorced/widowed/separated
702
50 (1.5)
815
50 (1.5)
a
*Significant values at 0.05 level of significant using Chi square p-value. sample frequency. b
weighted percentage and Standard errors.
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Prevalence of dietary supplements use among adults 65 years and older using NHANES
2009-2012
For this analysis, only the participants who were 65 years and older at the time of screening
and interview were included, and the total sample size was 2625 (Figure 4-2). Table 4-3 shows
the descriptive characteristics of older adults who were using DS in the past 30 days and those
who were using prescription medications with DS concurrently. The percentage reporting using
DS increased as the participants got older; 66% for 65-69, 42% for 70-74, 70% for 75-79, and
74% for 80≥. Among older females, 74% reported using DS in the past 30 days compared to
65% among male participants. Similar to the younger population, 74% of non-hispanic whites
reported using DS. Underweight older participants were more likely to use DS than normal
weight individuals. Also, similar to the younger population, as the family income increased the
percentage reporting DS use increased (65% for low, 75% for middle, and 74% for high family
income). 75% of graduate degree holders reported using DS in the past 30 days compared to
65% among high school degree holders. 74% of older adults who reported excellent or very good
health status reported using DS compared to 60% of those who reported fair or poor health
status. 70% of married participants and 72% of divorced participants reported using DS in the
past 30 days.
Seventy percent of older adults with elevation in systolic or diastolic blood pressure reported
using DS and 72% of older adult antihypertensive medication users reported using DS.
Seventy two percent of older adult prescription users reported using at least one DS in the past
30 days. Also, 73% of older adult who were taking four or more medications reported using DS
in the past 30 days. 63% of older adults reported deciding to take DS on their own, while 37% of
them reported taking DS based on their physician’s advice.
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In addition, Table 4-3 shows the characteristics of the older adult participants who reported
using at least one prescription medication plus one DS in the past 30 days. The oldest old (80
years old), females, non-hispanic whites, underweight, high family income, reported using
antihypertensive medications, and taking four or more prescription medications are more likely
to report using prescription medication along with DS in the past 30 days.

Figure 4-2 Flow chart showing the distribution of the older adult population (65 years old) who
reported using DS in NHANES 2009-2012
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Table 4-3 The Prevalence and characteristics of those who reported using DS in the past 30 days and
those who reported both DS and prescription medications among the population 65 years and older,
NHANES 2009-2012.
Characteristic
DS use in the past 30 days
Use of Prescription medications with
DS in the past 30 days
Yes
No
Yes
No
Freqa W.%(SE)b Freqa W.%(SE)b Freqa W.%(SE)b Freqa W.%(SE)b
Age(years)*
65-69
443
66 (2.7)
305
34 (2.7)
386
59 (2.3)
361
41 (2.3)
70-74
453
42 (2.0)
227
27 (2.0)
413
66 (2.2)
267
34 (2.2)
75-79
307
70 (2.2)
168
30 (2.2)
285
64 (2.6)
190
36 (2.6)
80≥
510
74 (1.5)
212
25 (1.5)
490
71 (1.8)
230
28 (1.8)
Sex*
Male
782
65 (1.8)
521
34 (1.8)
704
59 (1.9)
598
41 (1.9)
Female
931
74 (1.2)
391
25 (1.2)
807
70 (1.1)
450
30 (1.1)
Race*
Non-Hispanic white
1047
74 (1.4)
408
26 (1.4)
965
68 (1.5)
488
32 (1.5)
Non-Hispanic black
294
58 (2.5)
217
42 (2.5)
277
56 (2.7)
234
44 (2.7)
Mexican American/other Hispanic
250
54 (2.4)
208
46 (2.4)
225
50 (2.3)
232
50 (2.3)
Other
122
58 (7.4)
79
42 (7.4)
107
53 (7.2)
94
47 (7.2)
BMI
Underweight
29
79 (5.2)
17
21 (5.2)
24
67 (7.7)
22
33 (7.7)
Normal
469
73 (1.9)
218
27 (1.9)
411
65 (2.3)
276
35 (2.3)
Overweight
598
70 (2.1)
327
30 (2.1)
552
65 (1.9)
372
35 (1.9)
Obese
574
68 (1.9)
326
32 (1.9)
548
65 (2.3)
351
35 (2.3)
Family income*
Low
774
65 (1.6)
525
35 (1.6)
711
60 (1.5)
586
40 (1.5)
Middle
574
75 (1.9)
231
25 (1.9)
523
69 (2.0)
282
31 (2.0)
High
278
74 (3.1)
104
26 (3.1)
259
69 (3.3)
122
31 (3.3)
Education*
High school or less
890
65 (1.5)
610
35 (1.5)
825
61 (1.5)
674
39 (1.5)
College degree
460
75 (2.1)
172
24 (2.1)
429
71 (2.4)
203
29 (2.4)
Graduate degree
358
75 (2.5)
127
24 (2.5)
316
67 (2.8)
167
32 (2.8)
Systolic/Diastolic elevation
Yes
579
70 (1.7)
328
29 (1.7)
534
65 (2.0)
372
35 (2.0)
No
1059
70 (1.6)
550
29 (1.6)
973
65 (1.6)
633
35 (1.6)
Antihypertensive medications
Yes
1121
72 (1.7)
546
28 (1.7)
1106
72 (1.7)
559
28 (1.7)
No
33
71 (8.1)
23
29 (8.1)
30
67 (8.1)
26
33 (8.1)
Health status*
Excellent/ very good
558
74 (1.6)
213
26 (1.6)
492
65 (1.9)
279
34 (1.9)
Good
623
72 (2.0)
304
27 (2.0)
589
70 (2.0)
337
30 (2.0)
Fair OR poor
397
60 (2.1)
301
39 (2.1)
370
57 (2.3)
326
42 (2.3)
Marital status
Married
960
70 (1.4)
497
30 (1.4)
866
63 (1.6)
589
36 (1.6)
Never married
66
62 (6.1)
39
38 (6.1)
61
57 (7.0)
44
42 (7.0)
Divorced/widowed/separated
685
72 (1.6)
376
27 (1.6)
646
68 (1.4)
414
31 (1.4)
Polypharmacy*
Yes
988
73 (1.7)
427
26 (1.7)
988
73 (1.7)
427
26 (1.7)
No
725
67 (1.4)
485
33 (1.4)
586
56 (1.6)
621
44 (1.6)
Prescription medications use*
Yes
1574
72 (1.3)
774
28 (1.3)
1574
72 (1.3)
774
27 (1.3)
No
139
56 (4.8)
135
44 (4.8)
0
0
274
100 (0)
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Characteristic

DS use in the past 30 days
Freqa

Yes
W.%(SE)b

Freqa

No
W.%(SE)b

Use of Prescription medications with
DS in the past 30 days
Yes
No
Freqa W.%(SE)b Freqa W.%(SE)b

Source of DS*
Decided to take it for reasons of my
905
63 (2.1)
0
0
own
A doctor or other health provider
540
37 (2.1)
0
0
advised me to take it
*Significant values at 0.05 level of significant using Chi square p-value. a Sample frequency. b Weighted percentage and Standard
errors.
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Prevalence of use of specific types of dietary supplements and the most commonly reported
reason for use of each product among older adults
In this section, the trends in use of each type of DS and the most common reported reason for
use of each DS among older adults will be presented. Multi-vitamin and multi-minerals
(MVMM) was the most common type of DS use reported by older adults (23.18%) and the
primary reason for use was “to maintain health or to stay healthy” (29%). The second most
common DS used was calcium (17.05%) which was used mainly for “bone health” (70%).
Vitamin D was the third most frequently used (10.30%) and was also used for “bone health”
(31%). Vitamin C use was reported by 9.22% to “prevent cold” (45%), followed by Omega-3
(8.44%) used mainly for “heart health and cholesterol” (40%). Vitamin B-12 was reported by 5%
and was used mainly to “get more energy” (40%). Joint supplements, iron, botanicals, vitamin E,
folic acid, multivitamins, magnesium, potassium, vitamin B-6, vitamin A, niacin, and fiber were
the lowest DS reported by older adults used by 5% or less each. The complete list of DS use is
reported in Table 4-5. Women were more likely to use each of the DS types than men except for
niacin, where men reported higher use.
In general, most older adults reported taking DS in the past 30 days in order to maintain their
health or to stay healthy (18.15%). The second most commonly reported reason was to improve
overall health (17%), and the third most common reason was for bone health 15%. Other reasons
for use are reported in Table 4-4.
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Table 4-4 Prevalence of reported reasons for using DS among older adults in the United States,
NHANES 2009-2012.

Reported reason for DS use
1-To maintain health (to stay healthy)
2-To improve my overall health
3-For bone health
4-For heart health, cholesterol
5-Other
6-To supplement my diet, food not enough
7-To get more energy
8-For healthy joints, arthritis
9-To prevent colds, boost immune system
10- For eye health
11-For anemia, such as low iron
12-To prevent health problems
13-For good bowel/colon health
14-For skin health, dry skin
15-For muscle related issues
16-For mental health
17-For weight loss
18-For teeth, prevent cavities

Frequency
779
692
653
337
324
259
219
202
186
145
113
106
74
70
47
38
10
1
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Weighted %
18.14
16.73
14.96
8.44
7.76
5.73
4.68
4.62
5.00
3.53
1.98
2.49
2.01
1.75
1.38
0.60
0.11
0.00

Table 4-5 Prevalence of use for each supplement and the most common reason reported for each type of supplement among older adults (65
years and older), NHANES 2009-2012.

Men (N & W.%)¶
n= 1005

Women (N & W.%)¶
n= 1484

Most common reported reason for use

Users reporting
this reason W.% ¶

MVMM

Overall (N &
W.%)¶
n= 2489
574 (23.06)

275 (48)

299 (52)

To improve my overall health

31

Calcium

430 (17.27)

117 (27.20)

313 (72.9)

For bone health

73

Vitamin D

256 (10.28)

100 (39)

156 (61)

For bone health

32

Vitamin C

229 (9.20)

97 (42.35)

132 (57.64)

To prevent colds, boost immune system

45

Fiber

209 (8.39)

98 (46.88)

111 (53.11)

For good bowel/colon health

64

Vitamin B12

121 (4.86)

52 (43)

69 (57)

To get more energy

33

Niacin

116 (4.66)

57 (49.13)

59 (50.86)

For heart health, cholesterol

86

Omega-3/Fish oil

106 (4.25)

37 (35)

69 (65)

For heart health, cholesterol
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Multivitamins

85 (3.41)

41 (48.23)

44 (51.76)

To maintain health (to stay healthy)

33

Vitamin E

82 (3.29)

22 (26.82)

60 (73.17)

For heart health, cholesterol

24

Iron

76 (3.05)

31 (40.78)

45 (59.21)

For anemia, such as low iron

63

Joint Supplements

59 (2.37)

23 (39)

36 (61)

For healthy joints, arthritis

57

Potassium

40 (1.60)

14 (35)

26 (65)

For muscle related issues

29.5

Folic Acid

33 (1.32)

11 (33.33)

22 (66.66)

To maintain health (to stay healthy)

26.5

Vitamin B6

31 (1.24)

13 (42)

18 (58)

To improve my overall health

19

Vitamin A

18 (0.72)

5 (27.77)

13 (72.22)

For eye health

38.5

Magnesium

13 (0.52)

7 (54)

6 (46)

For bone health

27

Botanicals

11 (0.44)

5 (45.45)

6 (54.55)

For heart health, cholesterol

24

Type of
Supplement

¶ Sample

size and weighted percentage.
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The relationship between dietary supplement use and demographic and socioeconomic
characteristics among older adults
A logistic regression model was built to predict the factors that are associated with DS use
among older adults. After reviewing bivariate analyses and checking that model assumptions
were met, the final model was selected and is reported in Table 4-6. Outliers were assessed and
multicollinearity was tested as well and results are shown in the Appendix. Out of 12 predictors
evaluated in the logistic regressions model, eight predictors were significantly associated with
DS use in the past 30 days among older adults participants. Age, sex, race, annual family
income, health status, using medication in the past 30 days, and polypharmacy were significantly
associated with using DS among older adults. For every one year increase after 65 years the odds
of using DS increased by 1.032 (1.004-1.065). Females were 53% more likely to use DS in the
past month compared to male participants OR=1.533 (1.164-2.019). Non-hispanic whites were
significantly more likely to report using DS than non-hispanic blacks or Mexican Americans
(OR= 0.596 (0.435-0.817) and 0.621 (0.472-0.816) respectively). Those who reported a normal
BMI were 32% more likely to report using DS than overweight older participants OR=1.326
(1.037-1.697). Those who reported their health status as fair or poor were significantly less likely
to use DS compared to those who reported good health OR=0.576 (0.415-0.801). Using prescription
medications in the past 30 days was significantly associated with reporting DS use compared to those not
using prescription medications in the past month OR=1.77 (1.146-2.757). This means those who were
using prescription medication in the past 30 days were 77% more likely to use DS than those who were
not taking prescription medications in the past 30 days. Finally, those who were taking 4 or more
prescription medications were 34% more likely to use DS than those who were taking less than 4
prescription medications OR=1.347 (1.012-1.793). All the results were adjusted to age, sex, race,
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education, BMI, marital status, family income, hypertension diagnosis, health status, prescription
medications use, and polypharmacy.
Table 4-6 Logistic regression model of DS use among older adults, NHANES 2009-2012.

Factors
Age (continuous)
Sex
Male
Female
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American & other Hispanic
Other
Education
High school or less
College degree
Higher degree
BMI
Overweight
Underweight
Normal
Obese
Marital Status
Married
Never married
Divorced/Separated/Widowed
Family Income
Low
Middle
High
Systolic/Diastolic Elevation
No
Yes
Health Status
Good
Excellent/very good
Fair or poor

Adjusted OR (95% CI)¶
1.032 (1.004-1.065)*
Reference
1.533 (1.164-2.019)*
Reference
0.596 (0.435-0.817)*
0.621 (0.472-0.816)*
0.643 (0.322-1.285)
Reference
1.259 (0.852-1.861)
1.348 (0.988-1.841)
Reference
1.563 (0.634-3.850)
1.326 (1.037-1.697)*
0.946 (0.658-1.359)
Reference
0.748 (0.441-1.267)
1.121 (0.853-1.474)
Reference
1.452 (1.142-1.846)*
1.379 (0.931-2.042)
Reference
1.028 (0.805-1.312)
Reference
1.003 (0.794-1.266)
0.576 (0.415-0.801)*

Prescription Medication Use
No
Yes
Polypharmacy
No
Yes

Reference
1.778 (1.146-2.757)*
Reference
1.347 (1.012-1.793)*

*Significant values at 0.05 level of significance.
¶
Adjusted odds ratio and 95% confident interval.
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CHAPTER 5: DISCUSSION
This cross sectional study was conducted to determine the trends of DS use among the
younger and older adult population in the U.S. using nationally representative data (NHANES
2009-2012). Also, one of the main objectives of this study was to evaluate the most common
reasons behind using DS among older adults and the factors associated with DS use in the past
30 days. Moreover, this is the first study to focus specifically on older adults (65 years and
older). Main findings, strengths, limitations, future directions, and conclusion will be discussed
in this chapter.
Trends in DS use
Out of 14,000 participants in the two NHANES cohorts 2009-2012, 51% of those participants
reported using DS in the past 30 days among all ages 20 years and older, an increase of 3% over
the previous study using NHANES 2007-2010 (Bailey et al., 2013). Among the younger adult
population (20-64 years old), 47% used at least one DS in the past month. The percentage using
at least one DS in the past 30 days increased to 70.5% among older adults and this was higher
than in the NHANES 2007-2010 cohort where 67% reported DS use in the past 30 days (Bailey
et al., 2013). In our study, MVMM was the most common reported DS taken in the past 30 days
by the younger adult population (20-64 years of age) and older adults (65 years and older).
Thirty percent of the U.S. younger adult population reported using MVMM, while 23% of older
adults reported using MVMM. Calcium, vitamin D, vitamin C, and fiber were among the most
frequently reported DS used by the older adult population with 17%, 10%, 9%, and 8% of older
adults using these supplements respectively. In contrast, MVMM, calcium, omega-3, botanicals,
and vitamin C were the top reported DS in the recent study using the 2007-2010 cohort (Bailey
et al., 2013). Potassium, folic acid, vitamin B6, vitamin A, magnesium, and botanicals had the
44

lowest reported use among older adults (1.6%, 1.3%, 1.2%, 0.72%, 0.52%, and 0.44%
respectively).
Rationale for using DS among older adults
For this specific aim, only the older adult population (65 years and older) was considered. This
is the first study that focused on older adults specifically to determine the most common reasons
for using DS. The most common reason reported for using DS in the past 30 days by older adults
was to “Maintain their health/to stay healthy” (18.15%), followed by “To improve overall
health” (17%). Fifteen percent of older adults reported using DS for “bone health” and 8.5% of
them for ”heart health and cholesterol”. These results are consistent with the recent study that
was conducted by Bailey et al., (Bailey et al., 2013) where they evaluated all participants 20
years of age and older in the 2007-2010 NHANES cohort. Also, for each dietary supplement, the
most common reasons for use were explored. Niacin had the highest reported percentage (86%)
for a single reason for use, which was for “heart health or cholesterol”, followed by calcium with
73% for “bone health” and fiber with 64% for bowel health. Taking hypertension as an example
to consider the opportunity for drug-supplement interactions or disease-supplement interactions
in this study, 96% of older adults were taking antihypertensive medications at the same time
there were high percentage of them taking niacin for heart health, which may lead to increase
adverse drug reaction if a drug-supplement interaction is present. It is important to consider that
DS can enter the market without clinical studies assuring the efficacy or safety of the
supplement.
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Polypharmacy and prescription medications
70% of older adult DS users consumed at least one prescription medication in the past 30
days. This percentage is lower than the 90% of DS users who reported using prescription
medication in the GEM study (Nahin et al., 2009). Seventy one percent of the oldest old (80
years) reported using both prescription medication and DS in the past 30 days. The majority of
older participants who used four or more prescription medications reported using DS in the past
30 days. Polypharmacy itself is a major health issue among older adults that may lead to serious
health problem like falls, cognitive impairment, increase ER visits, and increased risk of drugdrug interactions (Maher, Hanlon, & Hajjar, 2014). Taking DS concurrently with multiple
medications may increase the chance of DS-drug interactions. For instance, in our study the
majority of older participants reported using calcium, which may interact with quinolone
antibiotic medications, thyroid medications or antiviral medications. Vitamin D was one of the
highest reported products in our study, which may interact with steroid medications. Vitamin C
may interact with amphetamine products. Moreover, supplements that contain calcium,
magnesium, gingko, and iron (Tsai, Lin, Simon Pickard, Tsai, & Mahady, 2012) are particularly
associated with a higher risk of DS-drug interactions. Although many older adults choose to use
DS because they believe that the DS is safe, there are side effects reported after using DS ranging
from severe to moderate (Palmer et al., 2003). It is important to increase patient and health care
provider awareness about DS efficacy and safety. Thirty-five percent of DS users were taking
supplements based on their physician’s advice and this percentage increased by 12% from that
reported in the previous study of the 2007-2010 NHANES cohort (Bailey et al., 2013). Also,
63% of DS users reported taking the supplement by their personal choice compared to 77% in
the previous study (Bailey et al., 2013). Health care professionals are responsible to ask patients
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about their DS and the reason behind using them in order to reduce the risk of adverse events and
interactions and potentially to avoid unnecessary costs.
Factors predicting using DS for older adults
In our study we found that being older, female, non hispanic white, normal weight, middle
income, having excellent or good reported health status, using at least one prescription
medication in the past 30 days, and using 4 or more medications in the past month were
significantly associated with using DS among older adult population in the U.S after adjusting
for other variables. Most of the previous studies examining predictors of DS using mixed age
groups of younger and older adults found similar results. Eileen et al. found in their study using
NHANES (2007-08) that there was an association between DS ues and being female, nonhispanic white, and higher educated only (Eileen T. Kennedy, Hanqi Luo, 2013). The more
recent study using the NHANES 2010 database by Bailey et al. (Bailey et al., 2013) reported that
females, older adults, non-hispanic whites, normal or overweight individuals, and those with
good or higher health status were more likely to use DS, which is similar to the findings reported
in our study.
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Strengths
This study aims to determine the prevalence of DS among adults of all ages and older adults
specifically. Also, it aims to understand the rationale for older adults to use DS. Strengths of this
study include:
-

A nationally representative cohort with large sample size was used, allowing study
outcomes to be generalizable to the entire US.

-

To our knowledge, this is the first study evaluating the reasons for taking DS among the
U.S. older adult population.

-

The most recently available NHANES database (2009-2010, 2011-2012) was used to
conduct this study, making it the most up-to-date report about DS use in the U.S.

-

An analysis of major health problems like hypertension was evaluated for its association
with using DS and for this specific predictor a measured variable rather than self reported
questionnaire data was used, which increased the reliability of the results. Data that was
related to hypertension was taking from MEC.

Limitations
This study has several limitations. First, the analysis is based on data from a self-reported
questionnaire, which may lead to overestimated or underestimated the prevalence. Also, different
types of bias might be a problem here such as recall bias, behavioral bias, and selection bias.
Second, participants in the NHANES study were only asked to report DS use over a short period
of time (last 30 days), which makes it difficult to determine if the DS was used for short-term or
long-term use, unlike other studies that asked the subjects about DS use in the past 6 or 12
months (Paula Gardiner et al., 2014). Third, reporting using DS or prescription medications does
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not guarantee that the subject actually took the DS or medication. Finally, this is a crosssectional study and can only evaluate associations and the prevalence of DS use rather than any
causal relationships.
Future Directions
Future research should focus on DS safety and efficacy to establish whether Food and Drug
Administration (FDA) oversight of DS is warranted. It is important to ensure that any product in
the market is safe and effective particularly for the older adult population. Randomized
controlled trials are expensive, but this is the best way to assess the efficacy and safety of each
supplement. In addition, more investigations are needed to understand the healthcare provider
knowledge and behavior regarding DS and alternative medicine. NHANES does not ask about
pharmacist recommendations regarding DS and this is also an important area of future study.
Studying DS use among assisted living facility residents and nursing home residents is also
needed area of future study, as these patients are more likely to be frail and have compromised
health and functional status.
Conclusion
In conclusion, a high percentage of older adults reported using DS in the past 30 days.
Similarly, a high percentage of older adults reported using DS concurrently with prescription
medications. Using DS was significantly higher among female, non-hispanic white, normal
weight, middle-income, polypharmacy patients, prescription medication users, and self-reported
excellent or good health status. Including questions related to DS use in patient medication
history in the medical record and carefully evaluating this DS use is important in order to deliver
safe and cost effective health care.
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Appendix
Multicollinearity checking:
Pearson Correlation Coefficients
Prob > |r| under H0: Rho=0
Number of Observations
SEX

RACE

Education

BMI

1.00000

0.00616

0.02164

0.03137

0.13513

0.3800

0.0190

<.0001

20293

20293

11758

0.00616

1.00000

SEX

RACE

Education

0.3800
20293

20293

0.02164

0.06083

0.0190
11758

0.03137
BMI

<.0001
18011

0.13513
Marital_status

<.0001
11767

HTN

health_status

RX

Polypharmacy

-0.03012

0.02544

0.04706

0.06777

-0.02784

<.0001

<.0001

0.0020

<.0001

18011

11767

19323

14801

12449

0.06083

0.10925

-0.04368

-0.06562

0.04479

0.10692

0.18924

0.13004

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

11758

18011

11767

19323

14801

12449

20282

20293

1.00000

0.09816

-0.09551

0.38800

0.08703

-0.31554

0.00235

0.09395

<.0001

<.0001

<.0001

<.0001

0.7986

<.0001

11748

11176

10823

10039

11750

11758

0.01077

-0.02592

0.15078

0.22275

0.28370

-0.27617

0.2538

0.0007

18011

11223

17188

0.01077

1.00000

-0.25490

<.0001
11758

<.0001
11758

0.10925

0.09816

<.0001

<.0001

18011

11214

0.04368

0.09551

<.0001

<.0001

11767

11748

11214

1.00000

Marital_status Family_income

0.2538
11223

<.0001
11767

53

11184

<.0001
14652
0.07950
<.0001
10832

<.0001
12310

0.09505
<.0001
10046

<.0001
20282

<.0001
18002
0.08220
<.0001
11759

<.0001
20293

<.0001
18011

-0.11255
<.0001
11767

Pearson Correlation Coefficients
Prob > |r| under H0: Rho=0
Number of Observations

Family_income

HTN

health_status

RX

SEX

RACE

Education

BMI

0.03012

0.06562

0.38800

0.02592

<.0001

<.0001

19323

19323

0.02544

0.04479

0.08703

0.0020

<.0001

<.0001

14801

14801

10823

0.04706

0.10692

0.31554

<.0001

<.0001

12449

12449

0.06777

0.18924

0.00235

<.0001

0.7986

20282

11750

0.13004

0.09395

<.0001

<.0001

20293

11758

<.0001
20282
0.02784

Polypharmacy

<.0001
20293

<.0001
11176

<.0001
10039

0.0007

Marital_status Family_income
-0.25490

1.00000

<.0001

HTN

health_status

RX

Polypharmacy

0.05333

-0.23525

0.01969

0.05813

<.0001

<.0001

0.0062

<.0001

11184

19323

14151

11910

-0.07950

0.05333

1.00000

-0.11234

0.19845

0.18790

<.0001

<.0001

<.0001

<.0001

<.0001

10832

14151

14801

12145

14793

14801

0.22275

0.09505

-0.23525

0.11234

1.00000

0.16008

-0.24404

<.0001

<.0001

<.0001

12310

10046

11910

0.28370

-0.08220

-0.01969

0.19845

-0.16008

<.0001

0.0062

<.0001

<.0001

11759

19313

14793

12442

20282

20282

-0.11255

0.05813

0.18790

-0.24404

0.47547

1.00000

<.0001

<.0001

<.0001

<.0001

<.0001

11767

19323

14801

12449

20282

17188
0.15078
<.0001
14652

<.0001
18002
0.27617
<.0001
18011

54

<.0001
12145

19313

<.0001
12449

12442

1.00000

19323

<.0001
12449

0.47547
<.0001

20293

Checking Outliers
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